AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15990070 — intervention group
Group type: EXPERIMENTAL
Intervention: Five different sets of inertial parameters
Number of subjects: 10
Study 12461391 — intervention group
Group type: EXPERIMENTAL
Intervention: OP‐1 Implant
Number of subjects: 20
Study 12461391 — intervention group
Group type: COMPARATOR
Intervention: Autograft bone
Number of subjects: 20
Study 10337884 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice pack applied for 10 minutes before catheter insertion
Number of subjects: 28
Study 10337884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ice pretreatment)
Number of subjects: 28
Study 10337884 — intervention group
Group type: COMPARATOR
Intervention: Preference for method (ice pretreatment vs no pretreatment)
Number of subjects: 28
Study 7795920 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAN/DSM-III-R assessment
Number of subjects: 706
Study 7795920 — intervention group
Group type: EXPERIMENTAL
Intervention: GAF score assessment
Number of subjects: 706
Study 2027058 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate, plaster of paris, and doxycycline composite graft
Number of subjects: 15
Study 2027058 — intervention group
Group type: COMPARATOR
Intervention: Surgical debridement alone (Control)
Number of subjects: 15
Study 7387242 — intervention group
Group type: EXPERIMENTAL
Intervention: SciMed membrane oxygenator
Number of subjects: 60
Study 7387242 — intervention group
Group type: COMPARATOR
Intervention: Harvey bubble oxygenator
Number of subjects: 60
Study 31192246 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and folinic acid (FUFA)
Number of subjects: 269
Study 31192246 — intervention group
Group type: COMPARATOR
Intervention: Folfiri
Number of subjects: 269
Study 29925889 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory theta-burst stimulation (TBS) applied to the right inferolateral prefrontal cortex (ilPFC)
Number of subjects: 0
Study 29925889 — intervention group
Group type: COMPARATOR
Intervention: Sham or excitatory TMS
Number of subjects: 0
Study 26800571 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 806
Study 26800571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time
Number of subjects: 806
Study 26800571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 806
Study 26800571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration variability
Number of subjects: 806
Study 25007676 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional laryngeal microsurgery
Number of subjects: 200
Study 25007676 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 W CO2 laser
Number of subjects: 200
Study 25007676 — intervention group
Group type: COMPARATOR
Intervention: 6 W CO2 laser
Number of subjects: 200
Study 22544644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 100 mg (40 μCi) [¹⁴C]‐lacosamide over 60 min
Number of subjects: 10
Study 22544644 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 100 mg (40 μCi) [¹⁴C]‐lacosamide as an oral solution
Number of subjects: 10
Study 20378999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 195
Study 20378999 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 195
Study 20378999 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (half-dose trandolapril plus half-dose valsartan)
Number of subjects: 195
Study 20378999 — intervention group
Group type: COMPARATOR
Intervention: Control (Trandolapril)
Number of subjects: 195
Study 20378999 — intervention group
Group type: COMPARATOR
Intervention: Control (Valsartan)
Number of subjects: 195
Study 17977544 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol prophylaxis
Number of subjects: 32
Study 17977544 — intervention group
Group type: COMPARATOR
Intervention: No danazol treatment (Control)
Number of subjects: 32
Study 15976785 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 78
Study 15976785 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 78
Study 11773543 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox therapy (70% helium and 30% oxygen)
Number of subjects: 38
Study 11773543 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox therapy
Number of subjects: 38
Study 11773543 — intervention group
Group type: COMPARATOR
Intervention: Control group (supportive care and nebulized epinephrine)
Number of subjects: 38
Study 9696169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (10 mg every 4 to 6 h as needed, up to four daily doses)
Number of subjects: 123
Study 9696169 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen-codeine (600 mg-60 mg every 4 to 6 h as needed, up to six daily doses)
Number of subjects: 123
Study 8134481 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 100
Study 8134481 — intervention group
Group type: COMPARATOR
Intervention: Temazepam
Number of subjects: 100
Study 2768601 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-designed educational programme providing complex role experiences
Number of subjects: 0
Study 2768601 — intervention group
Group type: EXPERIMENTAL
Intervention: Active exposure to and assumption of variegated roles in different settings
Number of subjects: 0
Study 47538 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-poor blood (L.P.B.)
Number of subjects: 40
Study 47538 — intervention group
Group type: COMPARATOR
Intervention: Whole blood and ordinary packed red blood-cells (R.B.C.)
Number of subjects: 40
Study 31423649 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 minutes delivery room skin-to-skin contact (DR-SSC)
Number of subjects: 88
Study 31423649 — intervention group
Group type: COMPARATOR
Intervention: 5 minutes visual contact (VC)
Number of subjects: 88
Study 31345462 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive sertraline (400 mg/day for 2 weeks, then 200 mg/day for 12 weeks, tapered over 3 weeks)
Number of subjects: 460
Study 31345462 — intervention group
Group type: COMPARATOR
Intervention: Placebo (standard therapy with 7-14 days of intravenous amphotericin B and oral fluconazole)
Number of subjects: 460
Study 31345462 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive sertraline
Number of subjects: 460
Study 31345462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study 28906040 — intervention group
Group type: EXPERIMENTAL
Intervention: lokivetmab (1–3.3 mg/kg, monthly injectable)
Number of subjects: 274
Study 28906040 — intervention group
Group type: COMPARATOR
Intervention: ciclosporin (5 mg/kg/once daily)
Number of subjects: 274
Study 25659998 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 792
Study 23896824 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC/AZA/ST
Number of subjects: 77
Study 23896824 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC/MMF/ST
Number of subjects: 77
Study 22734234 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (10 mg/d) and bicyclol (25 mg, tid.)
Number of subjects: 96
Study 22734234 — intervention group
Group type: COMPARATOR
Intervention: Adefovir dipivoxil (10 mg/d)
Number of subjects: 96
Study 19259899 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry
Number of subjects: 5
Study 19259899 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised CTG analysis
Number of subjects: 5
Study 17115982 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (8 to 15 sessions)
Number of subjects: 114
Study 17115982 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (100 to 200 mg daily)
Number of subjects: 114
Study 17115982 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 114
Study 17115982 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 114
Study 15095933 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel (Plavix) combination therapy
Number of subjects: 0
Study 15095933 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and warfarin combination therapy
Number of subjects: 0
Study 11134431 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (5 microgram/kg/day) for 7 consecutive days
Number of subjects: 60
Study 11134431 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control)
Number of subjects: 60
Study 11134431 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 60
Study 9502626 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase and subcutaneous heparin treatment
Number of subjects: 292
Study 9502626 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin
Number of subjects: 292
Study 9502626 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of F1.2
Number of subjects: 292
Study 9502626 — intervention group
Group type: EXPERIMENTAL
Intervention: Values 12 h after enrollment
Number of subjects: 292
Study 8044945 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/d)
Number of subjects: 306
Study 8044945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 2656331 — intervention group
Group type: EXPERIMENTAL
Intervention: PSK immunotherapy (n = 21)
Number of subjects: 38
Study 2656331 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 17)
Number of subjects: 38
Study 28128726 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 441
Study 28128726 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 441
Study 31845832 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-orthodontic aligned teeth
Number of subjects: 232
Study 31845832 — intervention group
Group type: COMPARATOR
Intervention: Pre-orthodontic crowded teeth
Number of subjects: 232
Study 31845832 — intervention group
Group type: COMPARATOR
Intervention: Pre-orthodontic missing teeth
Number of subjects: 232
Study 31220283 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based interval walking 150 min/wk for 12 weeks
Number of subjects: 39
Study 31220283 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 39
Study 27657997 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200 mg daily for 12 weeks)
Number of subjects: 64
Study 27657997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 26151785 — intervention group
Group type: EXPERIMENTAL
Intervention: Efinaconazole topical solution, 10%
Number of subjects: 0
Study 26151785 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 24143092 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced medications
Number of subjects: 80
Study 24143092 — intervention group
Group type: COMPARATOR
Intervention: Conventional medications
Number of subjects: 80
Study 21643784 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy-led education and self-management programme
Number of subjects: 127
Study 21643784 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 127
Study 20628481 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent postcard
Number of subjects: 684
Study 20628481 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent print messages
Number of subjects: 684
Study 20628481 — intervention group
Group type: COMPARATOR
Intervention: Adolescent flyer
Number of subjects: 684
Study 16261567 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine (noradrenergic agonist)
Number of subjects: 0
Study 12060475 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast Enhanced Phototrichogram (CE-PTG)
Number of subjects: 21
Study 12060475 — intervention group
Group type: COMPARATOR
Intervention: Control group (5 subjects)
Number of subjects: 21
Study 12060475 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp Coverage Scoring (SCS) method
Number of subjects: 21
Study 10825857 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Platinum Whitening Toothpaste with Fluoride
Number of subjects: 149
Study 10825857 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquafresh Advanced Whitening Toothpaste with Fluoride
Number of subjects: 149
Study 10825857 — intervention group
Group type: COMPARATOR
Intervention: Crest Regular Fluoride Toothpaste
Number of subjects: 149
Study 7480531 — intervention group
Group type: EXPERIMENTAL
Intervention: lorazepam
Number of subjects: 342
Study 7480531 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 342
Study 7480531 — intervention group
Group type: EXPERIMENTAL
Intervention: amitriptyline
Number of subjects: 342
Study 7480531 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 342
Study 7480531 — intervention group
Group type: EXPERIMENTAL
Intervention: benzodiazepines (lorazepam and alprazolam)
Number of subjects: 342
Study 7480531 — intervention group
Group type: EXPERIMENTAL
Intervention: all treatment groups
Number of subjects: 342
Study 2401176 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus chemotherapy
Number of subjects: 170
Study 2401176 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 170
Study 2401176 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical operation plus chemotherapy
Number of subjects: 170
Study 2401176 — intervention group
Group type: COMPARATOR
Intervention: Radical operation alone
Number of subjects: 170
Study 2401176 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical operation plus chemotherapy in Stage II and III lesions
Number of subjects: 170
Study 2401176 — intervention group
Group type: COMPARATOR
Intervention: Radical operation alone in Stage II and III lesions
Number of subjects: 170
Study 6772449 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical slow-release nitroglycerin
Number of subjects: 18
Study 6772449 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral slow-release nitroglycerin
Number of subjects: 18
Study 6772449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6364030 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg I.V. indomethacin just after diagnosis
Number of subjects: 24
Study 6364030 — intervention group
Group type: COMPARATOR
Intervention: Left untreated for 48 hours
Number of subjects: 24
Study 6364030 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V. or oral indomethacin (ad libitum) after 48 hours
Number of subjects: 24
Study 6364030 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V. indomethacin
Number of subjects: 24
Study 6364030 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical closure
Number of subjects: 24
Study 31430578 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (EST)
Number of subjects: 100
Study 31430578 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP)
Number of subjects: 100
Study 29848009 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextualised physical activity intervention
Number of subjects: 21
Study 29848009 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline to 12 weeks)
Number of subjects: 21
Study 26643530 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial hand towels
Number of subjects: 369
Study 26643530 — intervention group
Group type: COMPARATOR
Intervention: Control (education alone)
Number of subjects: 369
Study 25157725 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (3000 IU/kg)
Number of subjects: 495
Study 25157725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study 22818065 — intervention group
Group type: EXPERIMENTAL
Intervention: β(1)-AR blockade (Toprol-XL)
Number of subjects: 38
Study 22818065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 20599192 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning in dyadic minimal social situation over 200 rounds
Number of subjects: 0
Study 20599192 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning in multiplayer groups with strategic interaction and communication
Number of subjects: 0
Study 20599192 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation of decision-making in minimal social situations
Number of subjects: 0
Study 17507741 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated sports drink (CAF+CE)
Number of subjects: 16
Study 17507741 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-electrolyte (CE)
Number of subjects: 16
Study 17507741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 16
Study 16041631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 4% cream (LMX4)
Number of subjects: 54
Study 16041631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2.5% and prilocaine 2.5% (EMLA)
Number of subjects: 54
Study 16041631 — intervention group
Group type: COMPARATOR
Intervention: Dorsal penile block (DPNB)
Number of subjects: 54
Study 11843784 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 593
Study 11843784 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericardium 6 (p6) acupuncture
Number of subjects: 593
Study 11843784 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupuncture
Number of subjects: 593
Study 11843784 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture (control)
Number of subjects: 593
Study 9919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed patients
Number of subjects: 542
Study 9919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who remained both depressed and physically disabled
Number of subjects: 542
Study 9919320 — intervention group
Group type: COMPARATOR
Intervention: Patients whose depression and physical disability improved
Number of subjects: 542
Study 7576976 — intervention group
Group type: EXPERIMENTAL
Intervention: [131I]MIBG and hyperbaric oxygen
Number of subjects: 0
Study 7576976 — intervention group
Group type: COMPARATOR
Intervention: [131I]MIBG treatment alone
Number of subjects: 0
Study 2179782 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin 5000 units 2 hours before surgery and every 8 hours postoperatively (regimen I)
Number of subjects: 304
Study 2179782 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin 5000 units every 8 hours preoperatively (between two and nine doses) and every 8 hours postoperatively (regimen II)
Number of subjects: 304
Study 2179782 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (control group)
Number of subjects: 304
Study 7441675 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for depression, physician sensitization, and informational feedback to physicians
Number of subjects: 150
Study 31629851 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple lesion group
Number of subjects: 54
Study 31629851 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex lesion group
Number of subjects: 54
Study 30358032 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids and vitamin D supplementation
Number of subjects: 68
Study 30358032 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity resistance training
Number of subjects: 68
Study 27718137 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG)
Number of subjects: 921
Study 27718137 — intervention group
Group type: COMPARATOR
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 921
Study 25978109 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-rich water (0.9 L/day) for 10 weeks
Number of subjects: 68
Study 25978109 — intervention group
Group type: COMPARATOR
Intervention: Placebo water for 10 weeks
Number of subjects: 68
Study 24028941 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation (beetroot juice)
Number of subjects: 0
Study 24028941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21876446 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human erythropoietin (rHuEPO)
Number of subjects: 92
Study 21876446 — intervention group
Group type: COMPARATOR
Intervention: dose reduction
Number of subjects: 92
Study 21876446 — intervention group
Group type: EXPERIMENTAL
Intervention: granulocyte colony‐stimulating factor
Number of subjects: 92
Study 18761097 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 mg cortisol
Number of subjects: 85
Study 18761097 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 85
Study 18761097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 17605632 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (4 mg, i.v.)
Number of subjects: 90
Study 17605632 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate (30 mg, i.v., for 2 consecutive days every 3 mo; n = 60)
Number of subjects: 90
Study 17605632 — intervention group
Group type: EXPERIMENTAL
Intervention: Neridronate (100 mg, i.v., for 2 consecutive days)
Number of subjects: 90
Study 17605632 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (after crossover from pamidronate)
Number of subjects: 90
Study 17605632 — intervention group
Group type: EXPERIMENTAL
Intervention: Neridronate
Number of subjects: 90
Study 17605632 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 90
Study 14724101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) with a 5‐min ischemia followed by 5‐min perfusion before hepatic vascular exclusion
Number of subjects: 34
Study 12391349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 80 mg
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 80 mg vs Sumatriptan 50 mg
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of eletriptan vs Sumatriptan
Number of subjects: 1008
Study 12391349 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg vs both Sumatriptan doses
Number of subjects: 1008